Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Levy

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Transfusion|June 22, 2002
High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard doseFrançois Lefrère, Richard Delarue, Dominique Somme, et al.
Annals of Hematology|July 30, 2025
Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Annals of Hematology|October 13, 2025
Correction to: Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Leukemia & Lymphoma|October 31, 2006
Deciphering leukemic B-cell chronic lymphoproliferative disordersValérie Ugo, Nathalie Leporrier, Véronique Salaun, et al.
International Journal of Molecular Sciences|December 23, 2023
Identification of the Axis β-Catenin-BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their MicroenvironmentImane Mihoub, Tareck Rharass, Souhaïl Ouriemmi, et al.
Annals of Intensive Care|February 27, 2021
High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective studyNicolas Bonnet, Olivier Martin, Marouane Boubaya, et al.
American Journal of Hematology|March 6, 2025
TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell LymphomaGrégory Lazarian, Lotfi Chemali, Merieme Bensalah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 studyCaroline Oudot, Marie-Françoise Auclerc, Vincent Levy, et al.
Therapeutic Advances in Gastroenterology|February 27, 2018
Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized studyRobert Benamouzig, Mourad Benallaoua, Jean-Christophe Saurin, et al.
Plos One|January 21, 2022
Cytokines, chemokines and growth factors profile in human aqueous humor in idiopathic uveitisMarie-Hélène Errera, Ana Pratas, Sylvain Fisson, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Transfusion|June 22, 2002
High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard doseFrançois Lefrère, Richard Delarue, Dominique Somme, et al.
Annals of Hematology|July 30, 2025
Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Annals of Hematology|October 13, 2025
Correction to: Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Leukemia & Lymphoma|October 31, 2006
Deciphering leukemic B-cell chronic lymphoproliferative disordersValérie Ugo, Nathalie Leporrier, Véronique Salaun, et al.
International Journal of Molecular Sciences|December 23, 2023
Identification of the Axis β-Catenin-BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their MicroenvironmentImane Mihoub, Tareck Rharass, Souhaïl Ouriemmi, et al.
Annals of Intensive Care|February 27, 2021
High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective studyNicolas Bonnet, Olivier Martin, Marouane Boubaya, et al.
American Journal of Hematology|March 6, 2025
TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell LymphomaGrégory Lazarian, Lotfi Chemali, Merieme Bensalah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 studyCaroline Oudot, Marie-Françoise Auclerc, Vincent Levy, et al.
Therapeutic Advances in Gastroenterology|February 27, 2018
Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized studyRobert Benamouzig, Mourad Benallaoua, Jean-Christophe Saurin, et al.
Plos One|January 21, 2022
Cytokines, chemokines and growth factors profile in human aqueous humor in idiopathic uveitisMarie-Hélène Errera, Ana Pratas, Sylvain Fisson, et al.
Pageof 6